Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FERMENTA BIOTECH LIMITED M&A Activity 2020

Dec 3, 2020

60716_rns_2020-12-03_36b8830a-2bc1-4732-9288-a1e5cf9f7cf0.pdf

M&A Activity

Open in viewer

Opens in your device viewer

==> picture [452 x 67] intentionally omitted <==

F.No.:49/2020-21

December 03, 2020

Corporate Relations BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001

Subject: Joint Press Release intimation – Acquisition of 52% stake by Fermenta Biotech Limited’s US Subsidiary in AGD Nutrition, LLC

Ref: Scrip Code 506414

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 ( ‘Listing Regulations’ ) and further to our intimation to BSE Limited dated December 03, 2020 under Regulation 30 of Listing Regulations regarding acquisition of 52% membership interest by Fermenta Biotech Limited’s wholly owned subsidiary Fermenta Biotech USA, LLC in AGD Nutrition, LLC, we hereby enclose the Joint Press Release by Fermenta Biotech Limited and AGD Nutrition, LLC regarding the above acquisition.

This information will thereafter be uploaded on the website of the Company at www.fermentabiotech.com

Kindly take the above on record.

Thanking you,

Yours faithfully,

for FERMENTA BIOTECH LIMITED [FORMERLY KNOWN AS DIL LIMITED]

SRIKANT NATH SHARMA Digitally signed by SRIKANT NATH SHARMA DN: c=IN, o=Personal, postalCode=400607, st=Maharashtra, 2.5.4.20=2ab07dc675b7405348b9f50416c712c738a3c6f165ca6b8e70474cfdc158e5cb, pseudonym=7F84E8095CAE6C1952DF57BF115FE47CA8DC5DEB, serialNumber=C7CD7EC99ADAAE2C3BD286AC4378FFADD7148C27FF6647D896904FB3E2D0942E, cn=SRIKANT NATH SHARMA Date: 2020.12.03 11:03:30 +05'30'

Srikant N Sharma

Company Secretary CS Membership No: F3617

A-1501, Thane One, DIL Complex, Ghodbunder Road, Majiwade, Thane (W) 400610

Encl.: as above

==> picture [451 x 67] intentionally omitted <==

==> picture [91 x 44] intentionally omitted <==

==> picture [132 x 35] intentionally omitted <==

Joint Press Release

Fermenta Biotech Limited’s US-subsidiary acquires majority stake in AGD Nutrition LLC

Wilmington / Nacogdoches / Mumbai, December 3, 2020:

Fermenta Biotech Limited (FBL), India has announced that its wholly owned subsidiary Fermenta Biotech USA LLC (FBU), Wilmington, DE, has acquired a 52% stake in a US-based vitamin company, AGD Nutrition LLC (AGD), headquartered in Nacogdoches, Texas. The deal would combine the expertise of both companies and result in synergies that will bring in greater operational capabilities to enhance FBL’s footprint in the US market.

This collaboration will couple FBL’s competence in manufacturing and customer-driven innovation with AGD’s distribution strength in the US, which is a geography that commands a significant share of the global human and animal nutrition market. AGD, an established player in the vitamin market since 2002, will be instrumental in paving the way for FBL to gain greater customer access through its deep understanding of the North American market.

Commenting on the development, Mr Krishna Datla, Managing Director, Fermenta Biotech Ltd. said:

“AGD has been our valued partner for many years, and this strategic investment intensifies our longstanding mutually-beneficial relationship in the North American market. We are confident that this alliance will result in increased customer proximity and reaffirm our commitment towards our clientele as a sustainable partner for their nutritional ingredients’ requirements. We look forward to the opportunities that will emerge from this partnership in way of stronger relationships with customers in the fields of animal nutrition, pharmaceuticals and dietary supplements.”

Mr J. Bradley Reynolds, Director, AGD Nutrition LLC commented:

“This will be a landmark alliance, where FBL’s technologies and quality product offerings will complement AGD’s relationships with its robust customer base. It marks a milestone in our efforts to achieve sustainable as well as profitable growth and underlines our focus to boost product delivery in the nutritional ingredients segment.”

About Fermenta Biotech Limited (FBL):

Fermenta Biotech Ltd. (FBL) is one of the leading manufacturers of Vitamin D3 globally. It caters to over 300 customers across 50 countries with a worldwide distribution network for a variety of

1

==> picture [91 x 44] intentionally omitted <==

==> picture [132 x 35] intentionally omitted <==

applications such as pharmaceuticals, dietary and nutritional supplements, food, animal nutrition and rodenticides. FBL's manufacturing facilities in Kullu and Dahej are certificated by global accreditations and its world class R&D centre is located at Thane. Apart from Vitamin D3, FBL also possesses expertise in integrated biotechnology solutions such as enzymes for antibiotic synthesis and other niche APIs. For more information about the Company and its businesses, please visit our website www.fermentabiotech.com

About AGD Nutrition LLC:

AGD Nutrition LLC (AGD) was founded in 2002 and is shaped by professionals who have managed food and pharmaceutical advancements at leading multinational firms. Currently based out of Texas, AGD possesses expertise in animal nutrition, specifically, ingredients for feed applications. It is also a distinct player in the Food and Dietary Supplements domain across North America. Moreover, AGD commands strong relationships with its clientele, bringing customer proximity along with a wide distribution network across the continent. www.agdnutrition.com

Safe Harbor:

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. The company assumes no obligation to update forward-looking statements to reflect actual results changed assumptions or other factors.

For further details please contact:

For Fermenta Biotech Limited

Name : Mr. Prashant Nagre Designation : Chief Executive Officer Email ID. : [email protected]

For AGD Nutrition LLC

Name : Mr. J. Bradley Reynolds Designation : Director Email ID. : [email protected]

2